Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...

Among patients with atrial fibrillation and predominantly chronic coronary syndrome undergoing PCI with intravascular imaging ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Introduction Stroke remains a leading cause of disability and mortality worldwide, with an urgent need for novel therapeutic strategies to improve recovery. Bupropion hydrochloride, a ...

Actinogen Medical Limited (ASX: ACW) today announces that results from its proof-of-concept trial, entitled “A phase 2 ...

Researchers conducted a cross-sectional analysis of recent myeloma randomized clinical trials to evaluate the prevalence and characteristics of reporting spin in study findings.

H. Lundbeck A/S (Lundbeck) today announced that the last patient has been randomized in DEEp OCEAN (NCT06719141), a global Phase III clinical trial evaluating the efficacy, safety and tolerability of ...

A study by researchers at U.S. health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...

Background Drug-coated balloon (DCB) angioplasty has emerged as a potential stent-free strategy for percutaneous coronary ...

Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA ...

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...